{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:17:16Z","timestamp":1791317836443,"version":"4.3.1"},"reference-count":98,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["316978"],"award-info":[{"award-number":["316978"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2016.00416","type":"journal-article","created":{"date-parts":[[2016,9,11]],"date-time":"2016-09-11T23:11:26Z","timestamp":1473635486000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome"],"prefix":"10.3389","volume":"10","author":[{"given":"Sarah","family":"Gerasch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Seif","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewgeni","family":"Jakubovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten R.","family":"M\u00fcller-Vahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1005653411471","article-title":"The Autism Spectrum Quotient (AQ): evidence from Asperger Syndrome\/high-functioning autism, males and females, scientists and mathematicians","volume":"31","author":"Baron-Cohen","year":"2001","journal-title":"J. Autism Dev. Disord."},{"key":"B3","volume-title":"Neuropsychologie der Depression","author":"Beblo","year":"2015"},{"key":"B4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J. Pers. Assess."},{"key":"B6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mds.21859","article-title":"Aripiprazole: a treatment for severe coprolalia in \u201crefractory\u201d Gilles de la Tourette syndrome","volume":"23","author":"Ben Djebara","year":"2008","journal-title":"Mov. Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/brain\/awl050","article-title":"Neural correlates of tic generation in Tourettesyndrome: an event-related functional MRI study","volume":"129","author":"Bohlhalter","year":"2006","journal-title":"Brain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/15622970500474770","article-title":"Aripiprazole in patients with Tourette syndrome","volume":"7","author":"Bubl","year":"2006","journal-title":"World J. Biol. Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/cap.2007.061","article-title":"Aripiprazole in children and adolescents with tourette disorder with and without explosive outbursts","volume":"18","author":"Budman","year":"2008","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-Label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1212\/01.wnl.0000327890.02893.61","article-title":"The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation","volume":"71","author":"Cavanna","year":"2008","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eurpsy.2009.12.024","article-title":"German validation of the Conners Adult ADHD Rating Scales-self-report (CAARS-S) I: factor structure and normative data","volume":"26","author":"Christiansen","year":"2011","journal-title":"J. Assoc. Eur. Psychiatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1017\/S1461145706006833","article-title":"Aripiprazole is effective in the treatment of Tourette's disorder","volume":"9","author":"Constant","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1089\/cap.2009.0125","article-title":"Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China","volume":"20","author":"Cui","year":"2010","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/hup.798","article-title":"A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole","volume":"21","author":"Davies","year":"2006","journal-title":"Hum. Psychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40263-015-0278-3","article-title":"Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism","volume":"29","author":"De Bartolomeis","year":"2015","journal-title":"CNS Drugs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1176\/appi.ajp.162.3.625","article-title":"Aripiprazole in a patient vulnerable to side effects","volume":"162","author":"Dehning","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/1745017901107010107","article-title":"Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study","volume":"7","author":"Delle Chiaie","year":"2011","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"B19","first-page":"597","article-title":"Clinical experience of long-term treatment with aripiprazole (Abilify) in children and adolescents at the child and adolescent psychiatric clinic 1 in Roskilde, Denmark","volume":"72","author":"Diom\u0161ina","year":"2015","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1017\/S1461145712000740","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"16","author":"Dold","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/08830738060210042403","article-title":"Aripiprazole in childhood and adolescence for Tourette syndrome","volume":"21","author":"Duane","year":"2006","journal-title":"J. Child Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/0145445513504432","article-title":"Premonitory Urges in Adults With Complicated and Uncomplicated Tourette Syndrome","volume":"38","author":"Eddy","year":"2013","journal-title":"SAGE J. Behav. Modif."},{"key":"B23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/JCP.0b013e31817dd520","article-title":"Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study","volume":"28","author":"Findling","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B24","volume-title":"German Version Obsessive Compulsive Inventory Revised (OCI-R)","author":"Foa","year":"2009"},{"key":"B25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1345\/aph.1G331","article-title":"Acute Dystonia with Low-Dosage Aripiprazole in Tourette's Disorder","volume":"40","author":"Fountoulakis","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1469-8749.2000.tb00346.x","article-title":"An international perspective on Tourette syndrome: selected findings from 3.500 individuals in 22 countries","volume":"8","author":"Freeman","year":"2000","journal-title":"Dev. Med. Child Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1024\/1422-4917\/a000049","article-title":"Eine medikament\u00f6se Behandlungsalternative beim Tourette-Syndrom im Kindes- und Jugendalter","volume":"38","author":"Fr\u00f6lich","year":"2010","journal-title":"Z. Kinder Jugendpsychiatr. Psychother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/jnnp-2012-303033","article-title":"Are premonitory urges a prerequisite of tic inhibition in Gilles de la Tourette syndrome?","volume":"83","author":"Ganos","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B29","first-page":"200","article-title":"Systemic review of aripiprazole for the treatment of children and adolescents with tic disorders","volume":"17","author":"Ghanizadeh","year":"2012","journal-title":"Neurosciences"},{"key":"B30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/15748863113089990029","article-title":"A systematic review of the efficacy and safety of desipramine for treating ADHD","volume":"8","author":"Ghanizadeh","year":"2013","journal-title":"Curr. Drug Saf."},{"key":"B31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s10578-013-0427-1","article-title":"Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial","volume":"45","author":"Ghanizadeh","year":"2014","journal-title":"Child Psychiatry Hum. Dev."},{"key":"B32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/1531-8257(199905)14:3<502::AID-MDS1020>3.0.CO;2-G","article-title":"Advantages of a modified scoring method for the rush video-based tic rating scale","volume":"14","author":"Goetz","year":"1999","journal-title":"Mov. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s10072-011-0678-1","article-title":"Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome","volume":"32","author":"Gulisano","year":"2011","journal-title":"Neurol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.neubiorev.2012.10.014","article-title":"Pharmacological treatment of Gilles de la Tourette syndrome","volume":"37","author":"Hartmann","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B36","volume-title":"German Version Beck Depressions-Inventar (BDI-II)","author":"Hautzinger","year":"2006"},{"key":"B37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jamapsychiatry.2014.2650","article-title":"Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome","volume":"72","author":"Hirschtritt","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1590\/S1516-44462004000300015","article-title":"Aripiprazole and Tourette syndrome","volume":"16","author":"Hounie","year":"2004","journal-title":"Rev. Bras. Psiquiatr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/15622970902718147","article-title":"A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF)","volume":"10","author":"Ikenouchi-Sugita","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/17588928.2011.604717","article-title":"On the functional anatomy of the urge-for-action","volume":"2","author":"Jackson","year":"2011","journal-title":"J. Cogn. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-244X-12-109","article-title":"Quality of life in adults with Gilles de la Tourette Syndrome","volume":"12","author":"Jalenques","year":"2012","journal-title":"BMC Psychiatry"},{"key":"B42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0733-8619(05)70311-X","article-title":"Tourette syndrome. Phenomenology and classification of tics","volume":"15","author":"Jankovic","year":"1997","journal-title":"Neurol. Clin."},{"key":"B43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.jcp.0000150229.69124.66","article-title":"Treatment of tics in Tourette syndrome with aripiprazole","volume":"25","author":"Kastrup","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0165-0327(11)70004-0","article-title":"Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness","volume":"128","author":"Katzman","year":"2011","journal-title":"J. Affect. Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/15622970701762544","article-title":"Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients","volume":"10","author":"Kawohl","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1017\/S1461145709990393","article-title":"Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive\u2013compulsive disorder","volume":"12","author":"Lai","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00787-012-0278-5","article-title":"Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder","volume":"21","author":"Lebowitz","year":"2012","journal-title":"Eur. Child And Adolesc. Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(02)11526-1","article-title":"Tourette's syndrome","volume":"360","author":"Leckman","year":"2002","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1176\/ajp.150.1.98","article-title":"Premonitory urges in Tourette's syndrome","volume":"150","author":"Leckman","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1089\/cap.2009.0035","article-title":"Aripiprazole in children and adolescents with tourette's disorder: an open-label safety and tolerability study","volume":"19","author":"Lyon","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B52","volume-title":"German Version Beck Angst Inventar (BAI)","author":"Margraf","year":"2007"},{"key":"B53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1089\/cap.2011.0081","article-title":"Aripiprazole in children with tourette's disorder and comorbid attention-deficit\/hyperactivity disorder: a 12-week, open-label, preliminary study","volume":"22","author":"Masi","year":"2012","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jpsychires.2013.04.003","article-title":"Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study","volume":"47","author":"Masi","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.braindev.2015.08.006","article-title":"Self-initiated coping with Tourette's syndrome: effect of tic suppression on QOL","volume":"38","author":"Matsuda","year":"2016","journal-title":"Brain Dev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/JCP.0000000000000331","article-title":"Exacerbation of tics after combining aripiprazole with pimozide - a case with tourette syndrome","volume":"35","author":"Mazlum","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change (MADRS)","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/mds.22900","article-title":"Health-related quality of life in patients with Gilles de la Tourette's syndrome","volume":"25","author":"M\u00fcller-Vahl","year":"2010","journal-title":"Mov. Disord."},{"key":"B59","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jpsychores.2014.03.003","article-title":"Tourette patients' misbelief of a tic rebound is due to overall difficulties in reliable tic rating","volume":"76","author":"M\u00fcller-Vahl","year":"2014","journal-title":"J. Psychosom. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1017\/S1461145705005365","article-title":"Case series on the use of aripiprazole for Tourette syndrome","volume":"8","author":"Murphy","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/cap.2008.0149","article-title":"Open label aripiprazole in the treatment of youth with tic disorders","volume":"19","author":"Murphy","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"362","key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00362","article-title":"Imaging the where and when of tic generation and resting state networks in adult Tourette patients","volume":"28","author":"Neuner","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s11136-014-0814-5","article-title":"Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders","volume":"24","author":"Olariu","year":"2015","journal-title":"Q. Life Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4088\/PCC.v07n0605","article-title":"Aripiprazole for the treatment of Tourette's disorder","volume":"7","author":"Padala","year":"2005","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/00023210-200822050-00002","article-title":"Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence","volume":"22","author":"Pae","year":"2008","journal-title":"CNS Drugs"},{"key":"B66","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/1479972316634604","article-title":"Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease","volume":"13","author":"Phan","year":"2016","journal-title":"Chron. Respir. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00115-002-1447-4","article-title":"Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit\/hyperactivity","volume":"74","author":"Retz-Junginger","year":"2003","journal-title":"Nervenarzt"},{"key":"B68","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/brain\/123.3.425","article-title":"Tourette syndrome, associated conditions and the complexities of treatment","volume":"123","author":"Robertson","year":"2000","journal-title":"Brain"},{"key":"B69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders, part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00115-003-1622-2","article-title":"Tools for the diagnosis of attention-deficit\/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist","volume":"75","author":"R\u00f6sler","year":"2004","journal-title":"Nervenarzt"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00406-006-1001-7","article-title":"Psychopathological rating scales for diagnostic use in adults with attention-deficit\/hyperactivity disorder (ADHD)","volume":"256","author":"R\u00f6sler","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"415","key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00415","article-title":"New insights into clinical characteristics of Gilles de la Tourette Syndrome: findings in 1032 patients from a single German center","volume":"10","author":"Sambrani","year":"2016","journal-title":"Front. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/da.21996","article-title":"Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial)","volume":"29","author":"Sayyah","year":"2012","journal-title":"Depress. Anxiety"},{"key":"B74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5152\/tpa.2014.1947","article-title":"Aripiprazole treatment of children and adolescents with tourette disorder or chronic tic disorder","volume":"18","author":"Seo","year":"2008","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1001\/archpsyc.1973.01750310070010","article-title":"Treatment of Gilles de la Tourette's syndrome with haloperidol: review of 34 cases","volume":"28","author":"Shapiro","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"key":"B76","volume-title":"M.I.N.I. International Neuropsychiatric Interview Version 5.0","author":"Sheehan","year":"2006"},{"key":"B77","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/2045125314560739","article-title":"Aripiprazole versus quetiapine in treatment-resistant obsessive-compulsive disorder: a double-blind clinical trial","volume":"5","author":"Shoja Shafti","year":"2015","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11940-010-0095-4","article-title":"Treatment of tics and Tourette syndrome","volume":"12","author":"Singer","year":"2010","journal-title":"Curr. Treat. Options Neurol."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1177\/1087054715624230","article-title":"Evaluating the psychometric properties of the conners adult ADHD rating scales","author":"Smyth","year":"2016","journal-title":"J. Atten. Disord."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/jclp.20525","article-title":"Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist","volume":"64","author":"Sulkowski","year":"2008","journal-title":"J. Clin. Psychol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.ridd.2010.12.036","article-title":"Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review","volume":"32","author":"Taylor","year":"2011","journal-title":"Res. Dev. Disabil."},{"key":"B82","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.psychres.2015.04.043","article-title":"Patients with Gilles de la Tourette syndrome have widespread personality differences","volume":"228","author":"Trillini","year":"2015a","journal-title":"Psychiatry Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.psychres.2015.10.030","article-title":"Narcissistic vulnerability is a common cause for depression in patients with Gilles de la Tourette syndrome","volume":"230","author":"Trillini","year":"2015b","journal-title":"Psychiatry Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/s0033291707001730","article-title":"Measuring depression: comparison and integration of three scales in the GENDEP study","volume":"38","author":"Uher","year":"2008","journal-title":"Psychol. Med."},{"key":"B85","first-page":"581","article-title":"Generaliseerbaarheid van depressietrials naar de dagelijkse praktijk","volume":"57","author":"Van der Lem","year":"2015","journal-title":"Tijdschr. Psychiatr."},{"key":"B86","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/da.21958","article-title":"Predicting outcome of depression using the depressive symptom profile: the Leiden routine outcome monitoring study","volume":"29","author":"Van Noorden","year":"2012","journal-title":"Depress. Anxiety"},{"key":"B87","first-page":"885","article-title":"The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder","volume":"150","author":"Ward","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","article-title":"Systematic review: pharmacological treatment of tic disorders - efficacy of antipsychotic and alpha-2 adrenergic agonist agents","volume":"37","author":"Weisman","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1590\/1414-431X20143672","article-title":"Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder","volume":"47","author":"Wen","year":"2014","journal-title":"Br. J. Med. Biol. Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/JCP.0b013e31825ac2cb","article-title":"Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients","volume":"32","author":"Wenzel","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/archgenpsychiatry.2011.1528","article-title":"Randomized trial of behavior therapy for adults with Tourette syndrome","volume":"69","author":"Wilhelm","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/JCP.0b013e31817d86cc","article-title":"Aripiprazole in a Case Presenting With Tourette Syndrome and Disorder","volume":"28","author":"Winter","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B93","volume-title":"Strukturiertes Klinisches Interview f\u00fcr DSM-IV","author":"Wittchen","year":"1997"},{"key":"B94","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00004703-200512000-00001","article-title":"Premonitory Urge for Tics Scale \u2013 Initial Psychometric Results and Examination of the Premonitory Urge Phenomen in Youth with Tic Disorders","volume":"6","author":"Woods","year":"2005","journal-title":"J. Dev. Behav. Pediatr."},{"key":"B95","doi-asserted-by":"publisher","first-page":"12959","DOI":"10.1371\/journal.pone.0012959","article-title":"Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?","volume":"5","author":"Worbe","year":"2010","journal-title":"PLoS ONE"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.4088\/JCP.v68n0717","article-title":"An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders","volume":"68","author":"Yoo","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4088\/JCP.12m08189","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder","volume":"74","author":"Yoo","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"B98","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1089\/cap.2006.16.505","article-title":"A pilot study of aripiprazole in children and adolescents with Tourette's disorder","volume":"16","author":"Yoo","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:32:24Z","timestamp":1498329144000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fnins.2016.00416\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":98,"URL":"https:\/\/doi.org\/10.3389\/fnins.2016.00416","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]}}}